- Have any questions? Contact us!
- info@dr-rath-foundation.org
December 22, 2022
With word spreading that the United States Patent Office has awarded the Dr. Rath Research Institute five patents on micronutrient combinations for fighting human diseases, the […]
December 16, 2022
December 8, 2022
December 2, 2022
The results of a clinical trial for lecanemab, an experimental drug that is claimed to slow the destruction of the brain in Alzheimer’s disease, have been […]
November 25, 2022
According to the pharma industry, governments, and the mainstream media, the mRNA vaccines used against COVID-19 are proven to be safe and effective. Over the past […]
November 4, 2022
A new study published in the BMC Nutrition journal analyzes the long-suspected link between vitamin D deficiency and psoriasis. Examining 285 psoriasis patients and 317 healthy […]
October 28, 2022
Apparently not content with the billions of dollars it already receives from the multinational corporate sector and related non-state financiers, the World Health Organization (WHO) has quietly begun seeking still further funding directly from companies. Operating through a little-known WHO Foundation set up during the early days of the COVID-19 pandemic, the new funding drive is headed by Anil Soni, a former pharmaceutical executive who has been a senior advisor to the Bill & Melinda Gates Foundation. With WHO Foundation board members and other senior officials having additional conflicting histories and connections with organizations such as the World Economic Forum (WEF), the corporate money capture of the WHO and its activities has reached a new level of control.
October 20, 2022
A new systematic review of observational and interventional studies examines the use of antioxidants in patients with COVID-19. Published in the Food Science & Nutrition journal, the results demonstrate highly beneficial roles for this class of micronutrients in reducing inflammation, ventilation requirement, hospitalization, intensive care unit admission, mortality, and other aspects of coronavirus care. Confirming that intravenous supplementation with vitamin C significantly decreases mortality from COVID-19 in severe cases, and that studies show vitamin D, selenium, and zinc similarly play positive roles in fighting the disease, the researchers conclude that antioxidants can improve clinical outcomes.
